NO20031484D0 - Splitt kappe virus preparat - Google Patents
Splitt kappe virus preparatInfo
- Publication number
- NO20031484D0 NO20031484D0 NO20031484A NO20031484A NO20031484D0 NO 20031484 D0 NO20031484 D0 NO 20031484D0 NO 20031484 A NO20031484 A NO 20031484A NO 20031484 A NO20031484 A NO 20031484A NO 20031484 D0 NO20031484 D0 NO 20031484D0
- Authority
- NO
- Norway
- Prior art keywords
- split
- virus preparation
- mantle
- mantle virus
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18561—Methods of inactivation or attenuation
- C12N2760/18563—Methods of inactivation or attenuation by chemical treatment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18661—Methods of inactivation or attenuation
- C12N2760/18663—Methods of inactivation or attenuation by chemical treatment
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0024088A GB0024088D0 (en) | 2000-10-02 | 2000-10-02 | Novel compounds |
GB0109288A GB0109288D0 (en) | 2001-04-12 | 2001-04-12 | Novel compounds |
PCT/EP2001/011328 WO2002028426A1 (en) | 2000-10-02 | 2001-10-01 | Split enveloped virus preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20031484D0 true NO20031484D0 (no) | 2003-04-01 |
NO20031484L NO20031484L (no) | 2003-05-28 |
Family
ID=26245086
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20031484A NO20031484L (no) | 2000-10-02 | 2003-04-01 | Splitt kappe virus preparat |
Country Status (17)
Country | Link |
---|---|
US (1) | US20040028698A1 (no) |
EP (1) | EP1322329A1 (no) |
JP (1) | JP2004510747A (no) |
KR (1) | KR20030055275A (no) |
CN (1) | CN1253207C (no) |
AR (1) | AR030829A1 (no) |
AU (2) | AU1591402A (no) |
BR (1) | BR0114392A (no) |
CA (1) | CA2423610A1 (no) |
CZ (1) | CZ2003930A3 (no) |
HU (1) | HUP0302636A3 (no) |
IL (1) | IL155073A0 (no) |
MX (1) | MXPA03002890A (no) |
NO (1) | NO20031484L (no) |
NZ (1) | NZ525076A (no) |
PL (1) | PL362964A1 (no) |
WO (1) | WO2002028426A1 (no) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4359654B2 (ja) * | 1996-01-30 | 2009-11-04 | ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア | 抗原特異的免疫応答を生起させる遺伝子発現ベクターおよびその使用方法 |
BR0114392A (pt) * | 2000-10-02 | 2003-09-02 | Glaxosmithkline Biolog Sa | Formulação de vacina, método para produzir uma formulação de vacina, uso de uma preparação de vacina contra rsv dividido, kit para liberação de uma formulação de vacina intranasal, dispositivo de liberação intranasal, e, método para proteger ou tratar um mamìfero susceptìvel a, ou sofrendo de doença causada por rsv |
MY134424A (en) | 2001-05-30 | 2007-12-31 | Saechsisches Serumwerk | Stable influenza virus preparations with low or no amount of thiomersal |
US20050123550A1 (en) * | 2003-05-12 | 2005-06-09 | Laurent Philippe E. | Molecules enhancing dermal delivery of influenza vaccines |
US7588774B2 (en) | 2003-05-12 | 2009-09-15 | Becton, Dickinson And Company | Molecules enhancing dermal delivery of influenza vaccines |
CN1305526C (zh) * | 2003-12-29 | 2007-03-21 | 薛平 | 乙型脑炎病毒裂解疫苗及其制备方法 |
WO2006091722A2 (en) * | 2005-02-23 | 2006-08-31 | Uab Research Foundation | Alkyl-glycoside enhanced vaccination |
JP5006196B2 (ja) | 2005-08-01 | 2012-08-22 | 久光製薬株式会社 | 経皮または経粘膜投与のためのアジュバントおよび製剤 |
RU2392965C2 (ru) * | 2006-01-26 | 2010-06-27 | Пфайзер Продактс Инк. | Новые гликолипидные адъювантные композиции |
GB0622282D0 (en) * | 2006-11-08 | 2006-12-20 | Novartis Ag | Quality control methods |
US20100047327A1 (en) * | 2007-01-31 | 2010-02-25 | Tetsuji Kuwahara | Adjuvant for Transdermal or Transmucosal Administration and Pharmaceutical Preparation Containing the Same |
US11446374B2 (en) | 2008-12-09 | 2022-09-20 | Novavax, Inc. | Modified RSV F proteins and methods of their use |
SI2370099T1 (sl) | 2008-12-09 | 2016-08-31 | Novavax, Inc. | Modificirani proteini RSV F in postopki njihove uporabe |
CA2803444A1 (en) * | 2010-06-29 | 2012-01-05 | Universite Laval | Use of leukotriene b4 in combination with a toll-like receptor ligand, a rig-l-like receptor ligand or a nod-like receptor ligand to enhance the innate immune response |
KR20140033171A (ko) * | 2011-05-26 | 2014-03-17 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 비활성화된 뎅기 바이러스 백신 |
US9993549B2 (en) | 2013-10-31 | 2018-06-12 | Hisamitsu Pharmaceutical Co., Inc. | Adjuvant composition, adjuvant preparation containing same, and kit |
CA2930634C (en) * | 2013-11-15 | 2023-05-09 | Novartis Ag | Removal of influenza nuclear protein (np) from influenza virus preparations |
FR3025107B1 (fr) | 2014-08-29 | 2018-10-05 | Calixar | Procede de preparation d'un antigene vaccinal, antigene vaccinal obtenu et utilisations |
CN114617959A (zh) | 2015-09-03 | 2022-06-14 | 诺瓦瓦克斯股份有限公司 | 具有改进的稳定性和免疫原性的疫苗组合物 |
US12083228B2 (en) | 2017-07-24 | 2024-09-10 | Novavax, Inc. | Methods and compositions for treating respiratory disease |
MX2020009682A (es) | 2018-03-19 | 2020-10-12 | Novavax Inc | Vacunas de nanoparticulas multivalentes contra la influenza. |
US11576960B2 (en) | 2018-03-30 | 2023-02-14 | Georgia State University Research Foundation, Inc. | Respiratory syncytial virus (RSV) vaccines |
CN110665002B (zh) * | 2019-10-29 | 2023-01-24 | 信阳市动物疫病预防控制中心 | 一种用于防治牛病毒性腹泻的抗体制剂及其制备方法 |
CN113804593B (zh) * | 2020-06-11 | 2024-05-24 | 北京科兴生物制品有限公司 | 一种裂解疫苗裂解效果的检测方法及应用 |
JP2023532544A (ja) * | 2020-07-01 | 2023-07-28 | メディミューン,エルエルシー | 生物学的製剤を精製するための洗浄剤及び方法 |
CN112190705A (zh) * | 2020-09-25 | 2021-01-08 | 广州源博医药科技有限公司 | 一种rsv-sh亚单位疫苗及其制备方法和应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1486557A (en) * | 1973-10-18 | 1977-09-21 | Flockhart & Co | Process for the preparation of pyrogen-free sub-unit vaccine |
DE2829089A1 (de) * | 1977-07-13 | 1979-02-01 | Sandoz Ag | Subunit-vakzine |
DE2750045A1 (de) * | 1977-11-09 | 1979-05-10 | Behringwerke Ag | Verfahren zur entfernung von detergentien aus virusantigensuspensionen |
FR2475572A1 (fr) * | 1980-02-11 | 1981-08-14 | Pasteur Institut | Procede pour l'obtention de fragments de virus a enveloppe lipidique, en particulier d'antigenes utilisables comme vaccins, produits obtenus et applications |
AT405939B (de) * | 1997-02-24 | 1999-12-27 | Immuno Ag | Verfahren zur inaktivierung von lipidumhüllten viren |
NZ506603A (en) * | 1998-04-09 | 2002-10-25 | Smithkline Beecham Biolog S | Adjuvant compositions comprising polyoxyethylene ether or polyoxyethylene ester |
WO2001082965A1 (en) * | 2000-05-03 | 2001-11-08 | Medimmune, Inc. | Combination therapy of respiratory diseases using antibodies |
BR0114392A (pt) * | 2000-10-02 | 2003-09-02 | Glaxosmithkline Biolog Sa | Formulação de vacina, método para produzir uma formulação de vacina, uso de uma preparação de vacina contra rsv dividido, kit para liberação de uma formulação de vacina intranasal, dispositivo de liberação intranasal, e, método para proteger ou tratar um mamìfero susceptìvel a, ou sofrendo de doença causada por rsv |
-
2001
- 2001-10-01 BR BR0114392-1A patent/BR0114392A/pt not_active Application Discontinuation
- 2001-10-01 MX MXPA03002890A patent/MXPA03002890A/es unknown
- 2001-10-01 HU HU0302636A patent/HUP0302636A3/hu unknown
- 2001-10-01 PL PL01362964A patent/PL362964A1/xx unknown
- 2001-10-01 EP EP01986267A patent/EP1322329A1/en not_active Withdrawn
- 2001-10-01 CZ CZ2003930A patent/CZ2003930A3/cs unknown
- 2001-10-01 NZ NZ525076A patent/NZ525076A/en unknown
- 2001-10-01 AU AU1591402A patent/AU1591402A/xx active Pending
- 2001-10-01 WO PCT/EP2001/011328 patent/WO2002028426A1/en not_active Application Discontinuation
- 2001-10-01 KR KR10-2003-7004718A patent/KR20030055275A/ko not_active Application Discontinuation
- 2001-10-01 AR ARP010104630A patent/AR030829A1/es unknown
- 2001-10-01 AU AU2002215914A patent/AU2002215914B2/en not_active Ceased
- 2001-10-01 CN CNB018198090A patent/CN1253207C/zh not_active Expired - Fee Related
- 2001-10-01 US US10/381,486 patent/US20040028698A1/en not_active Abandoned
- 2001-10-01 JP JP2002532250A patent/JP2004510747A/ja active Pending
- 2001-10-01 IL IL15507301A patent/IL155073A0/xx unknown
- 2001-10-01 CA CA002423610A patent/CA2423610A1/en not_active Abandoned
-
2003
- 2003-04-01 NO NO20031484A patent/NO20031484L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2002215914B2 (en) | 2004-08-19 |
AU1591402A (en) | 2002-04-15 |
NZ525076A (en) | 2004-09-24 |
IL155073A0 (en) | 2003-10-31 |
JP2004510747A (ja) | 2004-04-08 |
HUP0302636A2 (hu) | 2003-11-28 |
WO2002028426A1 (en) | 2002-04-11 |
KR20030055275A (ko) | 2003-07-02 |
NO20031484L (no) | 2003-05-28 |
WO2002028426A8 (en) | 2002-06-06 |
CZ2003930A3 (cs) | 2003-08-13 |
BR0114392A (pt) | 2003-09-02 |
CA2423610A1 (en) | 2002-04-11 |
PL362964A1 (en) | 2004-11-02 |
CN1253207C (zh) | 2006-04-26 |
CN1477973A (zh) | 2004-02-25 |
AR030829A1 (es) | 2003-09-03 |
HUP0302636A3 (en) | 2008-03-28 |
EP1322329A1 (en) | 2003-07-02 |
MXPA03002890A (es) | 2004-12-03 |
US20040028698A1 (en) | 2004-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20031484L (no) | Splitt kappe virus preparat | |
DE60126045D1 (de) | Kompressionsmanschette | |
DE60114785D1 (de) | Einführungshülse | |
ATE434092T1 (de) | Gebäude | |
NO20031483D0 (no) | Vaksine | |
DK1226127T3 (da) | Substituerede phenylsulfamoylcarboxamider | |
DE60114153D1 (de) | Substituierte arylpyrazine | |
NO20024172L (no) | Vaksine | |
AR028393A1 (es) | Iminoazidas substituidas | |
ID30187A (id) | Dongkrak jenis pantagraf | |
DE60125415D1 (de) | Formeinsatz | |
DE60143985D1 (de) | Os | |
EE200200420A (et) | Linesoliid - kristallivorm II | |
NO20030917L (no) | Anvendelse | |
NO20030239L (no) | Modifisert virus | |
DE50108881D1 (de) | Dimmer | |
DE50112662D1 (de) | Substituierte benzoylcyclohexenone | |
AR028302A1 (es) | Feniluracilos substituidos | |
FR2816486B1 (fr) | Bague | |
NO20023392D0 (no) | Preparat | |
DE60007360T2 (de) | Amorphe modifikation von torasemid | |
DE50006201D1 (de) | Bohle | |
ATA78799A (de) | Feststoffbrenner | |
UA4234S (uk) | Горшок | |
DK1335938T3 (da) | Apolipoprotein-konstruktion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |